Literature DB >> 6296034

Pharmacokinetics of ceftizoxime.

R E Cutler, A D Blair, E D Burgess, D Parks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6296034     DOI： 10.1093/jac/10.suppl_c.91

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  15 in total

Review 1.  Ceftizoxime: a third-generation cephalosporin active against anaerobic bacteria. Committee on Antimicrobial Agents, Canadian Infectious Disease Society.

Authors: 
Journal:  CMAJ       Date:  1990-06-01       Impact factor: 8.262

2.  Cephalosporin assays.

Authors:  J B Ward; P B Harper
Journal:  Drugs       Date:  1987       Impact factor: 9.546

3.  Crossover assessment of serum bactericidal activity and pharmacokinetics of five broad-spectrum cephalosporins in the elderly.

Authors:  R G Deeter; M P Weinstein; K A Swanson; J S Gross; L C Bailey
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

4.  In vitro susceptibilities of five Leptospira strains to 16 antimicrobial agents.

Authors:  S Oie; K Hironaga; A Koshiro; H Konishi; Z Yoshii
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

5.  Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.

Authors:  E D Burgess; A D Blair
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

Review 6.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

Review 7.  Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.

Authors:  J Singh; B Burr; D Stringham; A Arrieta
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

8.  In vitro activity of cefotetan compared with that of other antimicrobial agents against anaerobic bacteria.

Authors:  H M Wexler; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

Review 9.  Clinical pharmacokinetics of the third generation cephalosporins.

Authors:  L Balant; P Dayer; R Auckenthaler
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

Review 10.  Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R C Heel
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.